Name Funds holding
in top 10
Growth Growth % Return since
30 Jun ‘17
51
2 +1 +100% 10.5%
52
2 +1 +100% 1.82%
53
2 +1 +100% 12.1%
ABUS icon
54
Arbutus Biopharma
ABUS
$837M
2 +1 +100% 18.1%
55
2 +1 +100% 97.4%
56
2 +1 +100% 18.4%
57
2 +1 +100% 28.5%
58
2 +1 +100% 28%
59
2 +1 +100% 1.7%
60
2 +1 +100% 39.8%
ZVRA icon
61
Zevra Therapeutics
ZVRA
$598M
2 +1 +100% 84.2%
62
2 +1 +100% 28.9%
63
2 +1 +100% 16.5%
64
2 +1 +100% 51.5%
65
2 +1 +100% 99.3%
66
2 +1 +100% 21.4%
67
2 +1 +100% 161%
68
2 +1 +100% 79.5%
69
2 +1 +100% 4.53%
70
13 +6 +86% 74%
71
7 +3 +75% 195%
72
10 +4 +67% 19.8%
73
5 +2 +67% 81.5%
74
5 +2 +67% 0.86%
75
5 +2 +67% 14.3%